StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Monday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of CO opened at $1.00 on Monday. The firm has a market cap of $121.55 million, a price-to-earnings ratio of 1.56 and a beta of 0.16. The business’s 50 day moving average is $1.21 and its two-hundred day moving average is $1.35. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.
About Global Cord Blood
See Also
- Five stocks we like better than Global Cord Blood
- Retail Stocks Investing, Explained
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Where to Find Earnings Call Transcripts
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Why Invest in 5G? How to Invest in 5G Stocks
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.